Zhenwei Yao
Doctor, Chief Physician, Doctoral Supervisor
Huashan Hospital, Fudan University

Doctor, chief physician, doctoral supervisor
Executive Deputy Director of Radiology Department of Huashan Hospital, Fudan University
Vice Chairman of former Neurology Group of Chinese Society of Radiology
Vice Chairman of former Youth Group of Chinese Society of Radiology
Vice Chairman of Special Committee for Imaging of Shanghai Society of Biomedical Engineering
Member and Leader of Neurology Group of Shanghai Society of Radiology
Member of the Standing Committee of Special Committee for Medical Imaging of Shanghai Association of Chinese Intergrative Medicine
SHARE Program Lecturer of Shanghai Society of Radiology

Kai Tang
Doctor of Medicine, Chief Physician
Tenth People's Hospital of Tongji University

Tang Kai, Doctor of Medicine, Chief Physician, Associate Professor, Postgraduate Supervisor, is currently the sub-discipline pacesetter of arrhythmia in the Heart Center of the Tenth People's Hospital of Tongji University and Executive Director of Atrial Fibrillation.
He is concurrently the standing member of the Working Committee for Electrophysiology of the Young and Middle-aged of Chinese Society of Pacing and Electrophysiology of Chinese Medical Association (CMA) and Chinese Society of Arrhythmias of Chinese Medical Doctor Association; member of Precision Cardiovasology Group of Chinese Society of Cardiology, CMA; youth member (6th session) of Chinese Society of Pacing and Electrophysiology, CMA; youth member (12th session) of Chinese Society of Internal Medicine, CMA; standing member of Heart Rhythm and ECG Branch of China International Exchange and Promotion Association for Medical and Healthcare; youth member (7th and 8th session) of Chinese Society of Biomedical Engineering Heart Rhythm Branch; trainer of Cardiovascular Intervention (Arrhythmia) Training Base of National Health Commission of the P.R.C.; editorial board member (5th session) of Chinese Journal of Cardiac Arrhythmias; member of the Committee for Prevention and Rehabilitation of Chinese Society of Cardiology, CMDA; standing member of Heart Rhythm Branch of Shanghai Society of Biomedical Engineering; member of Shanghai Stroke Association.
He successively studied the postgraduate and doctoral programs in Fuwai Cardiovascular Hospital Affiliated to Peking Union Medical College (currently known as National Heart Center) from 2001 to 2006. Upon graduation from the doctoral program in 2006, he began to work in the Department of Cardiology of the Tenth People's Hospital of Tongji University. Currently, he has completed more than 5,000 cardiac intervention operations. He is good at the catheter ablation for tachyarrhythmia and permanent pacing for chronic arrhythmia with rich experience in the clinical treatment and catheter ablation for arrhythmia such as supraventricular tachycardia, atrial fibrillation, atrial premature beats and ventricular premature beats. He was the first to publish the treatment strategy for the high-risk atrial fibrillation in apoplexy with CARTOMERGE and OVERLAY technology, combined catheter ablation and left atrial appendage occlusion in China.
He published 25 treatises on core domestic journals (six as the first author); published 18 SCI theses (eight as the first author); and participated in the edition of 11 treatises. He presided over one National Natural Science Foundation of China, and participated in three National Natural Science Foundations of China. He once obtained the Medical Science and Technology Award of Shanghai City twice, Scientific and Technological Progress Award of Shanghai City twice and was honored as "Shanghai Young Pacesetter of Science and Technology".
Expert consulting hours: Tuesday (all day) and Thursday afternoon

Wenbo Jiang
Executive Deputy Director of the 3D-printing Technology Clinical Translation Research Center
Shanghai Ninth People's Hospital

Jiang Wenbo is executive deputy director of the 3D-printing Technology Clinical Translation Research Center of the Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; deputy director of the Medical 3D-printing Innovation Research Center of Shanghai Jiao Tong University; director of Shanghai High-skilled 3D-printing Talent Training Base; chief engineer of Shanghai Additive Manufacturing Innovation Center; and vice president of Shanghai Additive Manufacturing Association. He also served as a distinguished expert at the Innovation Center for Science and Technology Leading Talents, and a distinguished researcher at the National Tissue Engineering Research Center. He is mainly engaged in the research and development of biomedical materials and equipment and advanced manufacturing technologies. Oriented to clinical transformation, Jiang Wenbo led the technical team of the 3D-printing center to design and prepare a variety of personalized medical device products, including customized rehabilitation devices, surgical guides, implants, etc. Such products, after being successfully applied in the clinic, have improved the accuracy of surgical treatment in clinical departments and greatly accelerated the popularization and application of advanced 3D-printing medical technologies. He has won the first prize of Shanghai Science and Technology Progress Award (2018), the first prize of Innovation Achievement Award of China Industry-University-Research Institute Collaboration Association (2019), and the first prize of Science and Technology Progress Award of China Sport Science Society (2018).

Ke Yang, Ph.D,
Researcher
Institute of metal research， Chinese Academy of Sciences

YANG Ke, Ph.D, Professor and Head of Specialized Materials & Devices Division, Institute of Metal Research, Chinese Academy of Sciences. He is the Standing Member of Chinese Biomaterials Association, the Fellow of International Union of Biomaterials Science and Engineering, and was the previous chair of Metallic Biomaterial Branch, Chinese Biomaterials Association. He is working in the areas of novel metallic biomaterials and applications, etc., including high-nitrogen nickel-free stainless steel, antibacterial metals, biodegradable metals, biofunctionalized metals, as well as applications in orthopedics, dentistry and coronary stents. He has published more than 500 journal papers and 10 books, and has been awarded more than 110 China Patents.

Xiaodong Fan
Vice Chairman
China Association for Medical Devices Industry（CAMDI）

Dr. Fan Xiaodong, Senior Engineer with legal professional qualification
He is the Vice Chairman of China Association for Medical Devices Industry, President and Editor-in-Chief of China Medical Devices Information Magazine, Chief Advisor of Health Industry of Deheng Law Firms, former Executive Deputy Director of Center for Medical Device Evaluation, NMPA, and member of the Specialized Technical Committee for Medical Devices of NMPA. He is the Doctor of Biomedical Engineering of Tsinghua University, Post-doctor of Physiology of Peking University, Visiting Professor of Central University of Finance and Economics, executive member of Chinese Society of Life Economics, member of Medical Devices Branch of China Instrument and Control Society, and member of Medical Data Industry Research Society of Zhejiang Province.
He has been engaged in the R&D, teaching, industrial management and supervision of medical device for nearly 40 years. He once undertook several NSFC and other scientific research projects, handled import & export tariff for medical products and APEC affairs, participated in the drafting of the first Administrative Regulations on the Supervision of Medical Devices in China, and drafted several departmental regulations. He is the initiator of the National Biological Economy Development Planning and Research (Medical device industry), initiator of the National Technical Economy Strategic Research (Medical device field), person in charge of the National Development Strategy of Medical Devices Industry in 2025, and Editor-in-Chief of Chinese History of Industry-Medical Device Chapter.

Roc Zha
Senior Scientist of Technology Center
Medtronic

Mainly engaged in mechanics analysis and computer modeling and simulation during the development of medical device. Graduated from Shanghai Institute of Technical Physics of the Chinese Academy of Sciences with a MS degree in 2006. He has over ten years of working experience with modeling and simulation in Dassault Systemes and Shanghai Jiangda, specializing in solid mechanics, material science and finite element analysis. Roc joined Medtronic in 2018 as a Senior Scientist to work on modeling and simulation and support product development and innovation.

Qiang Guo
R&D Director of X-ray Product Division
Siemens Shanghai Medical Equipment Ltd. (SSME)
Education:
Doctor of Pattern Recognition and Intelligent System, Shanghai Jiao Tong University
Experience:
He joined SSME in 2005, and served in the X-ray Product Divisionas the manager of image chainR&D, and the manager of hardware&system control and development,andin the SurgicalEquipmentDivision as R&D director. He is now R&D director of the X-ray Product Division.
Area of Expertise:
Image chain development and image quality evaluation of X-ray general radiotherapyproducts;
R&D of hardware and control system of X-ray general radiotherapy products;
DSAimage chain and image quality evaluation;
Development of C-type machine system for surgical operation;
R&D of X-ray general radiotherapy products.

Zhoushe Zhao
Vice dean of GE Healthcare (China）Precision Institution
GE Healthcare

Zhao Zhoushe, male, Doctor of Medicine. He is currently the vice dean of GE Healthcare (China）Precision Institution. Member of the Standing Committee of the Nuclear Medicine Equipment and Technology Branch of the Chinese Medical Equipment Society. In 1993, he obtained a doctorate degree in clinical nuclear medicine from Peking Union Medical College Hospital, Chinese Academy of Medical Sciences. Since 1999, SPECT/CT, PET/CT, PET/CT-MR and integrated PET/MR equipment have been used in clinic successively. It is the earliest clinician in China to use SPECT/CT, PET/CT and integrated PET/MR. Participated in the preparation of multiple monographs of PET/CT and PET/MR, and has experience in the clinical treatment of radionuclides for tumors and hemangiomas and the use of in vitro tests. Since 2003, he has participated in 5 projects of the 973 project, 1 project of the 863 project, and 2 major projects of the Ministry of Science and Technology. Since 2006, he has initiated and participated in three national PET/CT clinical studies and multi-center clinical studies comparing the clinical applications of PET and MR. In 2012, he began to focus on the research of pharmacokinetics, imaging genomics, imaging genomics, molecular targeted therapy and AI technology in image quantitative analysis. Since 2017, he has participated in the application of 4 technology patents at GE Healthcare（China).

Jingqiang Cui
President of Tuoren Group Research Institute
Henan Tuoren Group

Jingqiang Cui , doctor in engineering, is currently the President of Tuoren Group Research Institute and the Director of the Engineering Laboratory of Medical Polymer Materials and Products of Henan Province. He concurrently holds the posts of the standing member of the Surface and Interface EngineeringBranch of Chinese Society for Biomaterials, member of Henan Nonwovens and Industrial Textiles Association and the Expert Committee, executive member of the sixth council of Chinese Nuclear Society, and off-campus postgraduatesupervisor of Huazhong University of Science and Technology. He has been devoted to the research of medical materials and product development of the medical device industry. His research fields mainly include the technical research and application innovation such as surface modification of biomaterials, processing and modification of high polymer materials, biomaterials and implantable devices, sustained drug release, small-caliber artificial blood vessels and functional dressings. He has published more than 20 theses, and obtained two patents for invention, over ten utility model patents, four group standards and over ten product registration certificates.

David Zhang
Chief Scientist
Lifetech Scientific

Deyuan Zhang, Ph D, Professorship since 2003.
Chairman of Biotyx Medical (ShenZhen) Co. Ltd and Chief scientist of Lifetech Scientific Corporation(01302.HK), ex-President and Chief Technology Officer of Lifetech(01302.HK)
Members of National Standardization Technical Committee on Surgical Implants and Orthopedic Instrument and its cardiovascular branch, interventional medicine branch of Chinese Society of Biomedical Engineering, and surface engineering institution, Chinese Mechanical Engineering Society.
Members of Endovascular speciality Committee of China Medical Doctor Association and vice director of Vascular devices branch of China Association for Medical Devices Industry
As a key inventor, developed nano-coated cardiac occluders marketed in 100+ countries as well as bioresorbable materials and devices, of which bioresorbable iron-based scaffold clinical trials are ongoing in China and other countries.
Deeply involved in the drafting of national standards on cardiac occluders, vena cava filter, vascular stents and heart valves, and international standards on cardiac occluders and biodegradable metals
Obtain special subsidiary from the State Council of China since 2000. Granted the Second class Prize of National Technology Invention in 2014.

Jianjun Qiu
Medical Endoscopy Expert
SonoScape Medical Co. Ltd

Dr. Jianjun Qiu is a senior engineer, technical manager and medical endoscopy expert of SonoScape Medical Co. Ltd. He is awarded by "Shenzhen high-level professional talents" and "Top Ten Outstanding Young Workers of Shenzhen Nanshan district in 2019". Dr. Qiu has sucessfully led the development of the domestically initiative VLS-50 and VLS-55 series high power multi-spectral endoscopic light-source products, and SFI/VIST technologies that have been clinically used for early-cancer screening and diagnosis. Till now, he has applied for 18 invention patents (one of which entered the United State) and 9 utility model patents.

Kevin Li Ph.D
GM/VP
Micro Extrusion and Injection Business Unit
AccuPath Medical (Jiaxing) Co., Ltd.

Kevin Li, general manager of AccuPathMedical Technology (Jiaxing) Co., Ltd., bearer of doctoral degree in polymer material processing engineering, has 13-year work experience in high-end medical devices, has won first prize of Shanghai Science and Technology Progress Award, undertaken one Shanghai major project in strategic emerging industries, published more than 20 papers and applied for more than 30 patents.

Shiyi Wang
Product Director of Ventilators
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Shiyi Wang, native of Dandong, Liaoning, currently lives in Beijing.
From 1982 to 1988, he studied at Shanghai Medical College of Fudan University (formerly Shanghai Medical University), and was conferred a bachelor's degree in medicine.
From 1999 to 2001, he studied at the Business School of Stockholm University in Sweden and earned an MBA degree.
He had been engaged in and scientific research when had worked in National Health Commission of China (Supervision Bureau of the Ministry of Health), China Center for Disease Control (Chinese Academy of Preventive Medicine).
In 1995, he engaged in the marketing and sales of domestic ventilators. He have worked for well-known ventilator manufacturers at home and abroad, serving as a sales representative, sales manager, marketing manager, marketing director, and general manager in succession.
Now he is working for Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. as ventilator product director.

Yong Zhang
Executive Director and President
China Information Technology Consulting and Design Institute Co. Ltd.

Yong Zhang, Executive Director and President of China Information Technology Consulting and Design Institute Co. Ltd., Director of China Branch of BRICS Institute of Networks, Vice Chairman of Artificial Intelligence Industry Alliance, Vice Chairman of China Ultra High Definition Video Industry Alliance, Standing Member of Smart Energy Committee of Chinese Association for Artificial Intelligence, Invited standing Director of China National Association of Engineering Consultants, Standing Director of China Association of Communication Enterprises, Vice President of Communication Engineering Construction Branch of China Association of Communication Enterprises, Director of Design Committee of Communication Engineering Construction Branch of China Association of Communication Enterprises.

Edward Sun
R&D Director
MicroPort Orthopedics

Edward Sun, Master of Mechanical Engineering, Nanyang Technological University, Singapore. He is a member of the Chinese Arthroplasty Surface and Interface Society, Special Committee of Joint Surgery of the Chinese Research Hospital Association, and member of the Innovation and Transformation Group of the Orthopaedics Branch of the Chinese Association of Gerontology and Geriatrics. He successively worked with the R&D Center of DePuy Synthes and ASM Technology Singapore, engaging in new product development. He is currently the R&D director of the Minimally Invasive Orthopaedics Department, leading the research and development of new products of implants and supporting instruments in all fields of orthopaedics.

Qing Liu
CEO
Beijing Advanced Medical Technologies Ltd. Inc

Dr. Liu Qing is chairman of Beijing Advanced Medical Technologies Ltd. Inc. Following his role as R&D director at Celgene, a global biopharmaceutical company where he engaged himself in the R&D of the company's biomaterials and tissue engineering products, he returned to China in 2011 and established Beijing Advanced Medical Technologies Ltd. Inc. He also assumes the roles of deputy director at the Institute of Nanotechnology and Transformation Medicine, Shanghai East Hospital affiliated to Tongji University; director of the Research Center of Biomaterials and 3D Printing Medical Devices Engineering, Fudan Zhangjiang Institute; vice chairman of the Expert Committee on Vascular Transformation Medicine under the Chinese Branch of the International Union of Angiology; member of the standing committee of China Association for Medical Device Industry Vascular Devices Branch and director of the Chinese Society for Biomaterials.

Tianbai Yu
Deputy General Manager
Suzhou Microport Orthopedics Scientific (Group) Co., Ltd.

Master of Mechanical Engineering and MBA of Zhejiang University
He participated in the whole process of Johnson & Johnson manufacturing base in Suzhou from plant building, new product introduction to continuous improvement. After joining Microport Orthopedics, he took charge of the building and operation of Suzhou Plant and the Testing Center.
He was the member of the Orthopedic Implants Branch of National Technical Committee for Standardization of Surgical Implants and Orthopedic Instruments.
He applied for more then ten patents for invention and two software copyrights, and participated in the formulation and amendment of five industrial standards.

Jeffrey Chen
Sr. Research Manager
Medtronic Technology Center, Shanghai

Graduated from Beihang University, Ph. D.; PMP; CSSBB
Over 10 years of experience on new medical device development, system design and project management
Used to work at Mindray, Leica Biosystems (a Danaher company)
Professional at air and liquid sub-system design, system plan and integration on mechatronics device, design for reliability and lean manufacturing

Dr. Jian Fong TAN
Vice President of Advanced Technology
Peijia Medical Limited

Jian Fong TAN , is the Vice President of Advanced Technology of our Company. He also served as the engineering director and subsequently vice president of manufacturing at Achieva Suzhou from July 2006 to January 2012. Prior to joining our Group, Dr. Tan was the operation director at Bioridge Consulting from July 2016 to June 2019, in which he was primarily responsible for the development of medical devices. Dr. Tan had also served as assistant vice president of biomedical sciences division at Exploit Technologies Pte Ltd (ETPL) (now known as A*ccelerate), the commercialization arm of Agency for Science, Technology and Research (A*STAR), and director of new technologies at Biosensors Interventional Technologies Pte Ltd from February 2013 to February 2015.

Hurry Jiang
CEO, Dean of MinFound Institute of Nuclear Medicine Imaging System
MinFound Medical

Hurry Jiang graduated from Alfred University in May, 1995 and major in Ceramics. He had been worked in GE which is the Fortune 500 Company, and as CEO of MINFOUND MEDICAL SYSTEMS CO., LTD from March 2013. Dr. Jiang is one of the top international experts in CT detectors and materials, and was fully responsible for leading the R & D project of GEM detector and materials with a total of 50 million US dollars, and realized the industrialization of the project. He was invited to the "CT Energy Spectrum Technology Exploration Tour" held in Diaoyutai State Guesthouse, giving a keynote speech to more than 1000 medical imaging elites in China. Dr. Jiang's project team also won the 2010 industrial achievement award of the American Ceramic Society for its gem CT detector materials. He was introduced by the flagship talents (the most advanced) of Ningbo Institute of materials, Chinese Academy of Sciences, and obtained a subsidy of RMB 10 million to carry out the R & D and industrialization of detector materials and devices in May 2012. He has been authorized 16 American patents and published more than 50 SCI papers.

Alex Jiang
Quality Director of APAC
Smith & Nephew

Alex Jiang， Quality Director of APAC in Smith and Nephew. He has the overall responsibility for Quality Management in Research & Development， Manufacturing， and distribution & sales in this region. He has distinctive understanding of global Unique Device Identification (UDI) system under the global regulatory framework for medical devices， with his particular expertise of computer pattern recognition. He actively participates in promoting and developing the regulations and standards for the identification of medical devices. He has the systematic experience for labeling conversion， product registration information management and inventory management software systems. To meet the requirements of global UDI regulations， he built the integrated system， associating the standard process for product registration and the requirements of UDI， to control all kinds of labeling conversions， which has been certified under ISO13485 quality management system certification.

Wei Fan
Executive Director
Tencent Medical AI Labs

Dr. Wei Fan is the executive director of Tencent Medical AI Labs. His main interests are in using various artificial intelligence techniques-based digital therapeutics & digital biomarker for clinical problems, such as motion disorder syndrome (e.g., Parkinson's disease), cancer radiotherapy planning, heart failure early detection, etc. Dr. Fan received Ph. D. in Computer Science from Columbia University. He has been working in AI since 1995. He has over 150 top journals and conference papers with h-index of 62. He has received multiple best paper awards in top AI conferences and competitions. He served as the associate editor of ACM Transaction on Knowledge Discovery and Data Mining.

Norman Yuan
Senior Business Development Manager - Professional Solution Channel - Great China
Dassault Systemes

Norman Yuan, a LUMS MBA, currently works with Dassault Systèmes as senior business development manager at the Professional Client Business Department. Prior to joining Dassault, he has worked with EDF, Logitech and KPMG in the U.K., HP in China, etc. He is good at R&D management system consulting, PLM planning and consulting, project management system consulting and market demand management consulting, and has led/participated in many projects including 3D and PLM R&D platform of Haier Biomedical, 3D R&D platform of Heli Forklift, 3D R&D platform of Robotechnik Automation Co., Ltd., 3D R&D platform and PLM implementation project of Zhongya Machinery, PLM project of Tianneng Co., Ltd., 3D R&D and process platform project of NanFang Bearing, etc.

Omena Tian
Co-Founder & COO
VINNO Technology(Suzhou)Co.,Ltd

Tian Yuan, the co-founder and chief operating officer of Vinno Technology (Suzhou) Co., Ltd., has been honored as the Forbes's 2018 Most Promising Women in Chinese Business, the CCTV China Entrepreneurship Model and Jiangsu's Top 100 Female Entrepreneurs Serving the Pilot Program Talents for High-quality Development. She worked as a software engineer, R&D project manager, and after-sales services manager ofGeneral Electric Healthcare Group, a Fortune 500 enterprise. She participated in the R&D of the True Scan software platform and developed the world's first portable ultrasound device.Since her establishment of Tian Yuan founded Vinno Technology (Suzhou) Co., Ltd. in 2020, she led the team to develop an RF metadata ultrasound platform independently over the past one decade, which can collect the original diagnostic data which is 40 times clearer than the existing color ultrasound products in the market, taking the lead worldwide.The programs that Tian Yuan took charge of, such as "R&D of Radio Frequency Metadata Platform-based Trolley Ultrasonic Diagnostic Apparatus", won the Medical Progress Award of Jiangsu Province and the Suzhou Technical Invention Award successively. The handheld ultrasound program in the charge of her was selected as one of the national "13th Five-Year" major programs and was reported by CCTV's Heroes of Entrepreneurship in 2017, making it an highlight in the industry.

Dingzhong Han
Product Sales Manager
Carl Zeiss Shanghai Co., Ltd

Product sales manager of industrial quality solution from Carl Zeiss Shanghai Co.,Ltd, and member of technical committee from national product geometric technical standardization.
Since 2014, joined the working group of national standards regards to X-ray 3D measuring machine, in addition, coordinate and attend the ISO/TC 213 international conference of product geometric standardization (GPS).
Focus on coordinated measuring and sensor, high precision metrology, industrial CT, uncertainties, form measurement and national standards of product geometric technical standardization.

Shengyang Wang
Sales Engineer
Coherent Inc.

Responsible for the medical stent cutting market, have accurate grasp of the application of laser in medical stent.

Guangyin Yuan
Professor
Shanghai Jiao Tong University

Yuan Guangyin, a tenure track professor and doctoral supervisor of School of Materials Science and Engineering, Shanghai Jiao Tong University, has been selected for the program of New Century Excellent Talents and Shanghai Excellent Academic Leaders by the Ministry of Education. Currently, he holds the post of Deputy Director of Light Alloy Net Forming National Engineering Research Center, Shanghai Jiao Tong University, Director of Joint Research Center of Biomedical Materials, School of Materials Science and Engineering of Shanghai Jiao Tong University, Deputy Director of Medical Metal Materials Branch, Chinese Society for Biomaterials, and a standing committee member of Cardiovascular Materials Branch, Chinese Society for Biomaterials. He has engaged in the research of biodegradable medical metal materials for a long time, and overcame the international problem on the “uniform controllable degradation” of medical magnesium alloys, and he organized more than ten clinical trails, published more than 100 articles in the SCI journal. These articles have been cited for more than 4,000 times. He also was granted 22 patents, transferred 8 technologies, and won the first prize of Shanghai Science and Technology Progress Award.

Fuqing Zhong
Product Director, Project Development Department, R&D Center
Shanghai Colorful Magnetic Resonance Technology Co., Ltd

Zhong Fuqing, master of Biomedical Engineering, serves as the product director of Project R & D Department of Shanghai Colorful Magnetic Resonance Co., Ltd. Engaged in the development of medical imaging equipment for over one decade, he has gained thorough understanding of the R & D of medical devices as well as the process and system of the whole life cycle. He is also familiar with the regulations and standards with regard to medical devices and gained certain understanding of the medical industry. He has applied for 15 national patents successively.

Daozhi Liu
Founder and Managing partner
Sunland Capital

Liu Daozhi obtained the Bachelor and Doctor of Science in Nankai University respectively in 1985 and 1991. After the post-doctoral research in University of Oxford, he began to engage in scientific research as a professor and material scientist in National Institute for Material Science, University of Wollongong in Australia and Tianjin University. At the beginning of 2003, he returned to China from Australia, and joined Shanghai MicroPort (Group) Co., Ltd. (Hong Kong-listed company, stock code 00853) as one of the first leading talents of Shanghai City. He is a member of the core entrepreneurship team of Shanghai MicroPort. He successively assumed the Director, VP and Senior VP of Shanghai MicroPort R&D Center, and the General Manager of Shanghai MicroPort Orthopedics Co., Ltd., and led the establishment of three businesses, i.e. orthopedics, rhythm management and cardiac electrophysiology subordinate to Shanghai MicroPort. He won the highest national awards-National Invention Prize and National Prize for Progress in Science and Technology twice, and obtained more than 30 items of Chinese and international patent licensing. In 2014, he founded the Sunland Fund as the founding and managing partner. The company's scale of fund management amounts to RMB1.5 billion, and it has successfully invested in famous medical treatment projects such as LungHealth, GKH, Changzhou Surgray, GeneTech, Panda Medical and Upper Bio-tech Pharma. He has rich experience in the whole-process management including founding of professional medical fund, fundraising, team establishment, investment and post-investment management. He once assumed founders and members of several associations of the medical industry, including member of Chinese Society of Biomedical Engineering, member of Chinese Society of Biomaterials, one of the founders and two sessions of Vice Chairman of the Interventional Medicine Engineering Branch of Chinese Society of Biomedical Engineering, executive member of Vascular Devices Branch of China Association for Medical Devices Industry, founder and two sessions of Chairman of Specialized Committee for Medical Devices of Shanghai Biopharmaceutics Industry Association, visiting professor of Shanghai Jiaotong University, member of Shanghai Overseas Returned Scholars Association, Founding Chairman of Nankai Medical Health Alumni Association, as well as founder and nine successive sessions of Chairman of the famous China Healthcare Industry Investment and M&A CEO Summit.

An Liu
Founder and CEO
KAI MEDTECH INC

Mr. Liu An, since 2019, has served as the founder and CEO in KAI MEDTECH INC which has set up the R & D and production bases for medical devices in Shanghai and Hangzhou in China and California in USA, focusing on the independent R & D, production and sales of implantable and interventional medical devices. KAI MEDTECH INC has won a total of USD 17 million in the Pre-A round and A round investment from reputable investment institutions.
From 2017 to 2019, Mr. Liu An co-founded Hua Medtech Medical Devices (Shanghai) Co., Ltd. with A round financing of USD 15 million, obtained the agency right and CFDA registration certificate for the sales of Penumbra products in China, and successfully launched the marketing and sales of such products in Chinese market.
Mr. Liu An was appointed as the general manager of NAMSA Asia Pacific region from 2012 to 2017. At present, NAMSA is the world's largest one-stop industrial service platform for safety and effectiveness testing, research and development, pre-clinical study, clinical trials and regulatory consultation of professional medical devices.
Mr. Liu An worked in the USA medical device companies for ten years before 2012, including NAMSA USA, Medtronic, and 3M.